TGA Australia Media Releases
GovPing monitors TGA Australia Media Releases for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 10 changes logged to date.
Friday, April 17, 2026
Over 30,000 Illegal Vaping Goods Seized in Major TGA Operation, South-West Sydney
The TGA, assisted by NSW Police Force, seized over 30,000 illegal vaping goods from sites in Chipping Norton and Casula on 15 April 2026, with an estimated street value of $1.8 million. This enforcement action follows a significant investigation into unlawful online advertising, supply, and possession of commercial quantities of illegal vaping goods. The TGA warns that non-compliance with vaping offences under the Therapeutic Goods Act 1989 can result in penalties including up to 7 years imprisonment, or fines of up to $2.31 million for individuals and $23.1 million for corporations per offence.
Three Victorians Arrested, $2M Steroids and Peptides Seized in Joint ABF-TGA Operation
The Australian Border Force and Therapeutic Goods Administration announced the arrest of three Victorians and seizure of over $2 million worth of Performance and Image Enhancing Drugs (PIEDs), including more than 10,000 vials and 600 tablets of steroids and peptide products. The eight-month joint investigation, which began in August 2025 following the interception of 640 vials, led to criminal charges against three individuals for importing Tier 1 Goods (PIEDs). The TGA warned that unapproved peptide products present serious safety risks including contamination, infection, and tissue damage.
Wednesday, April 8, 2026
Stakeholders consulted on Andrographis removal from permitted medicines
TGA proposes removing Andrographis from permitted medicines
Thursday, March 26, 2026
TGA Issues Infringement Notices for Unlawful Importation of Therapeutic Goods
The TGA has issued infringement notices totalling $23,760 to three health practitioners for allegedly importing unapproved therapeutic goods unlawfully. These goods, including unregistered botulinum toxin and hyaluronic acid, have not been assessed by the TGA and may pose health risks.
TGA Opens Consultation on Sunscreen Regulation Improvements
The Therapeutic Goods Administration (TGA) has opened an 8-week public consultation on proposed improvements to sunscreen regulation in Australia. The consultation seeks feedback on options to enhance SPF testing reliability, adopt new technologies, strengthen laboratory oversight, and improve labelling and quality assurance.
Thursday, March 12, 2026
TGA Issues Infringement Notices for Unlawful Importation and Advertising
The Therapeutic Goods Administration (TGA) has issued 11 infringement notices totaling $43,560 to 6 individuals for alleged unlawful importation of unapproved therapeutic goods and unlawful advertising of prescription-only medicines. These actions underscore the TGA's commitment to protecting public health.
Prime Medic Group Fined for Unlawful Weight Loss Medicine Advertising
The Therapeutic Goods Administration (TGA) has issued infringement notices totaling $23,760 to Prime Medic Group and an individual for allegedly unlawfully advertising prescription-only weight loss medicines. Prime Medic Group paid the fines in January 2026.
TGA Seizes 57,000 Illegal Vaping Goods in NSW Crackdown
The Therapeutic Goods Administration (TGA) in Australia, with law enforcement support, seized over 57,000 illegal vaping products in Burwood, NSW. This action targets the illicit supply of vapes, with significant penalties including fines and imprisonment for non-compliance with the Therapeutic Goods Act 1989.
TGA Seizes Illegal Vapes Sold to Young People
The Therapeutic Goods Administration (TGA) in Australia, with police support, seized illegal vaping products from a store in Inverloch, Victoria, allegedly sold to minors. The TGA is investigating further regulatory action and warns retailers against targeting young people with illicit vapes.
TGA Releases Compliance Principles for 2026-2027 Enforcement
The Therapeutic Goods Administration (TGA) has released its compliance principles for 2026-2027, outlining a refreshed, proactive, and risk-based approach to enforcement for therapeutic goods in Australia. The principles apply across all TGA-regulated areas and will be reviewed every two years.
Get daily alerts for TGA Australia Media Releases
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source details
Activity
Browse Categories
Get TGA Australia Media Releases alerts
We'll email you when TGA Australia Media Releases publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.